Nasdaq Stockholm

Corline Biomedical AB

ISIN SE0006887451Filings at the FI

At a glance

Most recent filing on October 9, 2026 — a sale by Henrik Nittmar on Aug 26, 2026.

We hold 10 visible filings, going back to June 20, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 10 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 10. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Henrik Nittmar Chief executive officer
105,133 SEKOpen-market sale
TradedAug 26, 2026FiledOct 9, 2026
Henrik Nittmar Chief executive officer
145,400 SEKOpen-market buy
TradedFeb 17, 2026FiledFeb 17, 2026
Tomas Peter Lifvendahl Board member
89,500 SEKGrant
TradedMay 27, 2024FiledMay 27, 2024
Adam Dahlberg Chair of the board
3,300,000 sharesAdministrative
TradedApr 14, 2021FiledApr 15, 2021
Adam Dahlberg Chair of the board
35,475,000 SEKAdministrative
TradedMar 30, 2021FiledMar 30, 2021